Vera Therapeutics (VERA) Other Operating Expenses (2021)
Vera Therapeutics' (VERA) quarterly Other Operating Expenses came in at $16.0 million in Q3 2022, up 492.94% on a QoQ basis from $2.7 million in Q2 2021.
Powered by 
Analysis
Vera Therapeutics (VERA) Other Operating Expenses (2021) Analysis & Trends
Vera Therapeutics (VERA) has 2 years of Other Operating Expenses data on file, last reported at $16.0 million in Q3 2022.
- Quarterly Other Operating Expenses changed N/A year-over-year to $16.0 million in Q3 2022, while the trailing twelve-month figure through Jun 2023 was $16.0 million (changed N/A YoY) and the FY2021 annual result came in at $2.7 million, changed N/A from the prior year.
- Other Operating Expenses rose to $16.0 million in Q3 2022, from $2.7 million in the prior quarter.
- In the past five years, Other Operating Expenses ranged from a high of $16.0 million in Q3 2022 to a low of $2.7 million in Q2 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.31 Bn | 131.46 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.65 Bn | 77.66 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.46 Bn | 58.27 Bn | 1.37 Bn |
| 4 | Moderna | 57.94 Bn | 52.80 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.05 Bn | 44.05 Bn | - |
| 6 | BeOne Medicines | 39.96 Bn | 34.86 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.16 Bn | 31.85 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.44 Bn | 27.60 Bn | - |
| 9 | Insmed | 27.32 Bn | 26.16 Bn | 358.27 Mn |
| 10 | Vera Therapeutics | 2.56 Bn | 2.56 Bn | - |